Association of Warfarin Therapy with <i>APOE</i> and <i>VKORC1</i> Genes Polymorphism in Iranian Population

AuthorSajad Rafieeen
AuthorMasoumeh Rajabibazlen
AuthorReza Meshkanien
AuthorAzam Daraeien
AuthorMehryar Zargarien
AuthorFahimeh Sharafeddinen
AuthorZahra Fazelien
AuthorAttabak Toffani Milanien
AuthorMaryam Taherkhanien
Issued Date2017-07-31en
AbstractWarfarin is a vitamin K antagonist that genetic and non-genetic factors affected on its dose requirement in the patients with cardio vascular disease. The aim of this study was whether the APOE and VKORC1 polymorphisms influence on warfarin dose requirements in the part of Iranian patients. Blood samples were collected from 86 warfarin-treated patients. After extraction of genomic DNA, the VKORC1 (rs9923231) and the APOE (rs429358 and rs7412) polymorphisms were genotyped by PCR-RFLP technique. We found that the Iranian patients carrying genotypes GA or AA of VKORC1 polymorphism tended to receive lower dose of warfarin (p = 0.018). Furthermore, the E3/E3 genotype was observed with the frequency more than 60% in the patients with low dose of warfarin. The BMI and weight also showed a positive correlation with warfarin dose. However, it was not statistically significant (p > 0.05). The results of this study may be useful in defining of warfarin dose algorithms for Iranian patients.en
DOIhttps://doi.org/10.22037/ijpr.2017.2095en
URIhttps://brieflands.com/journals/ijpr/articles/124969en
KeywordWarfarin therapyen
Keyword<i>APOE</i> polymorphismsen
Keyword<i>VKORC1</i>en
KeywordIranian populationen
KeywordCardio vascular diseaseen
PublisherBrieflandsen
TitleAssociation of Warfarin Therapy with <i>APOE</i> and <i>VKORC1</i> Genes Polymorphism in Iranian Populationen
TypeOriginal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijpr-16-1230.pdf
Size:
262.08 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF